Global Measles and Rubella Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Measles and Rubella Vaccine market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Measles and Rubella Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Measles and Rubella Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measles and Rubella Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measles and Rubella Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Serum Institute of India Pvt. Ltd., Incepta Vaccine Ltd., GSK, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Measles and Rubella Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles and Rubella Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles and Rubella Vaccine, with price, sales quantity, revenue, and global market share of Measles and Rubella Vaccine from 2020 to 2025.
Chapter 3, the Measles and Rubella Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles and Rubella Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Measles and Rubella Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles and Rubella Vaccine.
Chapter 14 and 15, to describe Measles and Rubella Vaccine sales channel, distributors, customers, research findings and conclusion.
Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Measles and Rubella Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Measles and Rubella Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles and Rubella Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measles and Rubella Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measles and Rubella Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Serum Institute of India Pvt. Ltd., Incepta Vaccine Ltd., GSK, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Measles and Rubella Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Inactivated Vaccines
- Live Attenuated Vaccines
- Hospital
- Clinic
- Merck
- Serum Institute of India Pvt. Ltd.
- Incepta Vaccine Ltd.
- GSK
- Sanofi
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles and Rubella Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles and Rubella Vaccine, with price, sales quantity, revenue, and global market share of Measles and Rubella Vaccine from 2020 to 2025.
Chapter 3, the Measles and Rubella Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles and Rubella Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Measles and Rubella Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles and Rubella Vaccine.
Chapter 14 and 15, to describe Measles and Rubella Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles and Rubella Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Inactivated Vaccines
1.3.3 Live Attenuated Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles and Rubella Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Measles and Rubella Vaccine Market Size & Forecast
1.5.1 Global Measles and Rubella Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Measles and Rubella Vaccine Sales Quantity (2020-2031)
1.5.3 Global Measles and Rubella Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles and Rubella Vaccine Product and Services
2.1.4 Merck Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 Serum Institute of India Pvt. Ltd.
2.2.1 Serum Institute of India Pvt. Ltd. Details
2.2.2 Serum Institute of India Pvt. Ltd. Major Business
2.2.3 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product and Services
2.2.4 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.3 Incepta Vaccine Ltd.
2.3.1 Incepta Vaccine Ltd. Details
2.3.2 Incepta Vaccine Ltd. Major Business
2.3.3 Incepta Vaccine Ltd. Measles and Rubella Vaccine Product and Services
2.3.4 Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Incepta Vaccine Ltd. Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Measles and Rubella Vaccine Product and Services
2.4.4 GSK Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 GSK Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Measles and Rubella Vaccine Product and Services
2.5.4 Sanofi Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sanofi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLES AND RUBELLA VACCINE BY MANUFACTURER
3.1 Global Measles and Rubella Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Measles and Rubella Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Measles and Rubella Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Measles and Rubella Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Measles and Rubella Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Measles and Rubella Vaccine Manufacturer Market Share in 2024
3.5 Measles and Rubella Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measles and Rubella Vaccine Market: Region Footprint
3.5.2 Measles and Rubella Vaccine Market: Company Product Type Footprint
3.5.3 Measles and Rubella Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measles and Rubella Vaccine Market Size by Region
4.1.1 Global Measles and Rubella Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Measles and Rubella Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Measles and Rubella Vaccine Average Price by Region (2020-2031)
4.2 North America Measles and Rubella Vaccine Consumption Value (2020-2031)
4.3 Europe Measles and Rubella Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Measles and Rubella Vaccine Consumption Value (2020-2031)
4.5 South America Measles and Rubella Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Measles and Rubella Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Measles and Rubella Vaccine Consumption Value by Type (2020-2031)
5.3 Global Measles and Rubella Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Measles and Rubella Vaccine Consumption Value by Application (2020-2031)
6.3 Global Measles and Rubella Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Measles and Rubella Vaccine Market Size by Country
7.3.1 North America Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Measles and Rubella Vaccine Market Size by Country
8.3.1 Europe Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Measles and Rubella Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Measles and Rubella Vaccine Market Size by Country
10.3.1 South America Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Measles and Rubella Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Measles and Rubella Vaccine Market Drivers
12.2 Measles and Rubella Vaccine Market Restraints
12.3 Measles and Rubella Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measles and Rubella Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles and Rubella Vaccine
13.3 Measles and Rubella Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles and Rubella Vaccine Typical Distributors
14.3 Measles and Rubella Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles and Rubella Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Inactivated Vaccines
1.3.3 Live Attenuated Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles and Rubella Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Measles and Rubella Vaccine Market Size & Forecast
1.5.1 Global Measles and Rubella Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Measles and Rubella Vaccine Sales Quantity (2020-2031)
1.5.3 Global Measles and Rubella Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles and Rubella Vaccine Product and Services
2.1.4 Merck Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 Serum Institute of India Pvt. Ltd.
2.2.1 Serum Institute of India Pvt. Ltd. Details
2.2.2 Serum Institute of India Pvt. Ltd. Major Business
2.2.3 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product and Services
2.2.4 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.3 Incepta Vaccine Ltd.
2.3.1 Incepta Vaccine Ltd. Details
2.3.2 Incepta Vaccine Ltd. Major Business
2.3.3 Incepta Vaccine Ltd. Measles and Rubella Vaccine Product and Services
2.3.4 Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Incepta Vaccine Ltd. Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Measles and Rubella Vaccine Product and Services
2.4.4 GSK Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 GSK Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Measles and Rubella Vaccine Product and Services
2.5.4 Sanofi Measles and Rubella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sanofi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLES AND RUBELLA VACCINE BY MANUFACTURER
3.1 Global Measles and Rubella Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Measles and Rubella Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Measles and Rubella Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Measles and Rubella Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Measles and Rubella Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Measles and Rubella Vaccine Manufacturer Market Share in 2024
3.5 Measles and Rubella Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measles and Rubella Vaccine Market: Region Footprint
3.5.2 Measles and Rubella Vaccine Market: Company Product Type Footprint
3.5.3 Measles and Rubella Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measles and Rubella Vaccine Market Size by Region
4.1.1 Global Measles and Rubella Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Measles and Rubella Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Measles and Rubella Vaccine Average Price by Region (2020-2031)
4.2 North America Measles and Rubella Vaccine Consumption Value (2020-2031)
4.3 Europe Measles and Rubella Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Measles and Rubella Vaccine Consumption Value (2020-2031)
4.5 South America Measles and Rubella Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Measles and Rubella Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Measles and Rubella Vaccine Consumption Value by Type (2020-2031)
5.3 Global Measles and Rubella Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Measles and Rubella Vaccine Consumption Value by Application (2020-2031)
6.3 Global Measles and Rubella Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Measles and Rubella Vaccine Market Size by Country
7.3.1 North America Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Measles and Rubella Vaccine Market Size by Country
8.3.1 Europe Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Measles and Rubella Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Measles and Rubella Vaccine Market Size by Country
10.3.1 South America Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Measles and Rubella Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Measles and Rubella Vaccine Market Drivers
12.2 Measles and Rubella Vaccine Market Restraints
12.3 Measles and Rubella Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measles and Rubella Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles and Rubella Vaccine
13.3 Measles and Rubella Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles and Rubella Vaccine Typical Distributors
14.3 Measles and Rubella Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Measles and Rubella Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Measles and Rubella Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measles and Rubella Vaccine Product and Services
Table 6. Merck Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Merck Recent Developments/Updates
Table 8. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Serum Institute of India Pvt. Ltd. Major Business
Table 10. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product and Services
Table 11. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 13. Incepta Vaccine Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Incepta Vaccine Ltd. Major Business
Table 15. Incepta Vaccine Ltd. Measles and Rubella Vaccine Product and Services
Table 16. Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Incepta Vaccine Ltd. Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Measles and Rubella Vaccine Product and Services
Table 21. GSK Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. GSK Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Measles and Rubella Vaccine Product and Services
Table 26. Sanofi Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Sanofi Recent Developments/Updates
Table 28. Global Measles and Rubella Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 29. Global Measles and Rubella Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 30. Global Measles and Rubella Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 31. Market Position of Manufacturers in Measles and Rubella Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 32. Head Office and Measles and Rubella Vaccine Production Site of Key Manufacturer
Table 33. Measles and Rubella Vaccine Market: Company Product Type Footprint
Table 34. Measles and Rubella Vaccine Market: Company Product Application Footprint
Table 35. Measles and Rubella Vaccine New Market Entrants and Barriers to Market Entry
Table 36. Measles and Rubella Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Measles and Rubella Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 38. Global Measles and Rubella Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 39. Global Measles and Rubella Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 40. Global Measles and Rubella Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 41. Global Measles and Rubella Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 42. Global Measles and Rubella Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 43. Global Measles and Rubella Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 44. Global Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 45. Global Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 46. Global Measles and Rubella Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 47. Global Measles and Rubella Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 48. Global Measles and Rubella Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 49. Global Measles and Rubella Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 50. Global Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 51. Global Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 52. Global Measles and Rubella Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 53. Global Measles and Rubella Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 54. Global Measles and Rubella Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 55. Global Measles and Rubella Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 56. North America Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 57. North America Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 58. North America Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 59. North America Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 60. North America Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 61. North America Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 62. North America Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 63. North America Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 64. Europe Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 65. Europe Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 66. Europe Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 67. Europe Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 68. Europe Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 69. Europe Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 70. Europe Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 71. Europe Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 72. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 73. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 74. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 75. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 76. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 77. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 78. Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 79. Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 80. South America Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 81. South America Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 82. South America Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 83. South America Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 84. South America Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 85. South America Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 86. South America Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 87. South America Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 88. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 89. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 90. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 91. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 92. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 93. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 94. Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 95. Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 96. Measles and Rubella Vaccine Raw Material
Table 97. Key Manufacturers of Measles and Rubella Vaccine Raw Materials
Table 98. Measles and Rubella Vaccine Typical Distributors
Table 99. Measles and Rubella Vaccine Typical Customers
Table 1. Global Measles and Rubella Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Measles and Rubella Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measles and Rubella Vaccine Product and Services
Table 6. Merck Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Merck Recent Developments/Updates
Table 8. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Serum Institute of India Pvt. Ltd. Major Business
Table 10. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product and Services
Table 11. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 13. Incepta Vaccine Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Incepta Vaccine Ltd. Major Business
Table 15. Incepta Vaccine Ltd. Measles and Rubella Vaccine Product and Services
Table 16. Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Incepta Vaccine Ltd. Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Measles and Rubella Vaccine Product and Services
Table 21. GSK Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. GSK Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Measles and Rubella Vaccine Product and Services
Table 26. Sanofi Measles and Rubella Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Sanofi Recent Developments/Updates
Table 28. Global Measles and Rubella Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 29. Global Measles and Rubella Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 30. Global Measles and Rubella Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 31. Market Position of Manufacturers in Measles and Rubella Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 32. Head Office and Measles and Rubella Vaccine Production Site of Key Manufacturer
Table 33. Measles and Rubella Vaccine Market: Company Product Type Footprint
Table 34. Measles and Rubella Vaccine Market: Company Product Application Footprint
Table 35. Measles and Rubella Vaccine New Market Entrants and Barriers to Market Entry
Table 36. Measles and Rubella Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Measles and Rubella Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 38. Global Measles and Rubella Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 39. Global Measles and Rubella Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 40. Global Measles and Rubella Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 41. Global Measles and Rubella Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 42. Global Measles and Rubella Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 43. Global Measles and Rubella Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 44. Global Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 45. Global Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 46. Global Measles and Rubella Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 47. Global Measles and Rubella Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 48. Global Measles and Rubella Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 49. Global Measles and Rubella Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 50. Global Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 51. Global Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 52. Global Measles and Rubella Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 53. Global Measles and Rubella Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 54. Global Measles and Rubella Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 55. Global Measles and Rubella Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 56. North America Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 57. North America Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 58. North America Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 59. North America Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 60. North America Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 61. North America Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 62. North America Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 63. North America Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 64. Europe Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 65. Europe Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 66. Europe Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 67. Europe Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 68. Europe Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 69. Europe Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 70. Europe Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 71. Europe Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 72. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 73. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 74. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 75. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 76. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 77. Asia-Pacific Measles and Rubella Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 78. Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 79. Asia-Pacific Measles and Rubella Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 80. South America Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 81. South America Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 82. South America Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 83. South America Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 84. South America Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 85. South America Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 86. South America Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 87. South America Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 88. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 89. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 90. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 91. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 92. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 93. Middle East & Africa Measles and Rubella Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 94. Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 95. Middle East & Africa Measles and Rubella Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 96. Measles and Rubella Vaccine Raw Material
Table 97. Key Manufacturers of Measles and Rubella Vaccine Raw Materials
Table 98. Measles and Rubella Vaccine Typical Distributors
Table 99. Measles and Rubella Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Measles and Rubella Vaccine Picture
Figure 2. Global Measles and Rubella Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Measles and Rubella Vaccine Revenue Market Share by Type in 2024
Figure 4. Inactivated Vaccines Examples
Figure 5. Live Attenuated Vaccines Examples
Figure 6. Global Measles and Rubella Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Measles and Rubella Vaccine Revenue Market Share by Application in 2024
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Measles and Rubella Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Measles and Rubella Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Measles and Rubella Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 13. Global Measles and Rubella Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global Measles and Rubella Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Measles and Rubella Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Measles and Rubella Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Measles and Rubella Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Measles and Rubella Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Measles and Rubella Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Measles and Rubella Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Measles and Rubella Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Measles and Rubella Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Measles and Rubella Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global Measles and Rubella Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Measles and Rubella Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Measles and Rubella Vaccine Market Drivers
Figure 73. Measles and Rubella Vaccine Market Restraints
Figure 74. Measles and Rubella Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles and Rubella Vaccine in 2024
Figure 77. Manufacturing Process Analysis of Measles and Rubella Vaccine
Figure 78. Measles and Rubella Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Measles and Rubella Vaccine Picture
Figure 2. Global Measles and Rubella Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Measles and Rubella Vaccine Revenue Market Share by Type in 2024
Figure 4. Inactivated Vaccines Examples
Figure 5. Live Attenuated Vaccines Examples
Figure 6. Global Measles and Rubella Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Measles and Rubella Vaccine Revenue Market Share by Application in 2024
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Measles and Rubella Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Measles and Rubella Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Measles and Rubella Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 13. Global Measles and Rubella Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global Measles and Rubella Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Measles and Rubella Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Measles and Rubella Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Measles and Rubella Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Measles and Rubella Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Measles and Rubella Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Measles and Rubella Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Measles and Rubella Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Measles and Rubella Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Measles and Rubella Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global Measles and Rubella Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Measles and Rubella Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Measles and Rubella Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Measles and Rubella Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Measles and Rubella Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Measles and Rubella Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Measles and Rubella Vaccine Market Drivers
Figure 73. Measles and Rubella Vaccine Market Restraints
Figure 74. Measles and Rubella Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles and Rubella Vaccine in 2024
Figure 77. Manufacturing Process Analysis of Measles and Rubella Vaccine
Figure 78. Measles and Rubella Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
